Literature DB >> 4043953

The significance of mitotic rate: a retrospective study of 127 thyroid carcinomas.

T K Lee, R T Myers, R B Marshall, M G Bond, B Kardon.   

Abstract

The association between mitotic rate and biologic behavior was studied in 127 cases of thyroid cancer. Based on the observation of 12,700 high-power fields (HPF), the mitotic rate varied from 0 to 316 (33.3 +/- 4.9) mitoses/100 HPF. Mitotic rate differed among the four types of thyroid cancers and correlated inversely with the differentiation of the tumors, being highest (156.8 +/- 32.9) in the undifferentiated tumors and lowest (17.3 +/- 2.4) in the papillary tumors. By analysis of variance (AOVA), the relations between mitotic rate and the sex or age of the patient, maximal diameter of the tumor, and vascular or capsular invasion were assessed, but significant relations were not found (r2 = 44.2 per cent). Follow-up observation, possible in 74 patients, showed mitotic rate to be significantly related to the survival period (Student's t-test; P values ranging from 0.02 to 0.05). The patients who were alive five and ten years after surgery had had lower mitotic rates than those who had died during the same follow-up period. The correlation of low mitotic rate with a high degree of differentiation and low potential for invasion might, in part, explain the better surgical cure rates for papillary thyroid carcinoma than for other types of thyroid cancers.

Entities:  

Mesh:

Year:  1985        PMID: 4043953     DOI: 10.1016/s0046-8177(85)80282-3

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  5 in total

1.  Does delay in fixation affect the number of mitotic figures in processed tissue?

Authors:  S S Cross; R D Start; J H Smith
Journal:  J Clin Pathol       Date:  1990-07       Impact factor: 3.411

2.  Image analysis assisted study of mitotic figures in oral epithelial dysplasia and squamous cell carcinoma using differential stains.

Authors:  Ankita Tandon; Narendra Nath Singh; V R Brave; Gadiputi Sreedhar
Journal:  J Oral Biol Craniofac Res       Date:  2016-09-28

3.  Proliferating cell nuclear antigen (PCNA) in medullary thyroid carcinoma.

Authors:  A Skopelitou; P Korkolopoulou; A Papanikolaou; M Hadjiyannakis
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

4.  Proliferation Markers and Their Uses in the Study of Endocrine Tumors.

Authors:  Giuseppe Pelosi; Giuseppe Zamboni
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

5.  Rare Clinical Entity: Metastatic malignant struma ovarii diagnosed during pregnancy - Lessons for management.

Authors:  Corey J Lager; Ronald J Koenig; Richard W Lieberman; Anca M Avram
Journal:  Clin Diabetes Endocrinol       Date:  2018-06-19
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.